Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | KITE-222 |
Trade Name | |
Synonyms | KITE 222|KITE222 |
Drug Descriptions |
KITE-222 comprises autologous T-cells engineered to express a chimeric antigen receptor (CAR) that targets CLL1, potentially resulting in increased toxicity in CLL1-expressing tumor cells (NCI Thesaurus). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C178486 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cyclophosphamide + Fludarabine + KITE-222 | Cyclophosphamide Fludarabine KITE-222 | 0 | 1 |
KITE-222 | KITE-222 | 0 | 1 |